BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 24, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 11, 2024

View Archived Issues
Medically accurate illustration of a baby in the womb of a pregnant mother

Maternal-fetal cellular crosstalk could predict preterm labor

Listening to conversations between a mother and her unborn child on the cellular level could inform how the pregnancy is going and prevent complications. Three scientific groups from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), in collaboration with Wayne State University and Michigan State University, have used single-cell RNA sequencing techniques to decipher these words, identify the cellular language of these interactions in the placenta and establish a cellular atlas. Read More

NAT10 expression is reduced in new-onset ankylosing spondylitis

N-acetyltransferase 10 (NAT10) is an RNA cytidine acetyltransferase involved in multiple biological processes, such as inflammatory responses or osteogenic differentiation, and linked to pathological states such as asthma, viral infections, cancer, or laminopathies. Read More
Cervical cancer cell

GBP1 plays critical role in cervical cancer progression

The role that guanylate binding protein 1 (GBP1) plays in cervical cancer is still controversial. The effects of GBP1 on cervical cancer were investigated by Chinese researchers from the Xinjiang Medical University. Read More
Staphylococcus epidermidis under microscope

Hybrid peptide shows antibacterial, antibiofilm activities

Researchers from Thammasat University presented the discovery and preclinical characterization of... Read More

Dutch researchers patent new BUB1 inhibitors for cancer

Researchers at NTRC BV, Pivot Park Screening Centre BV (PPSC) and Universiteit Leiden have... Read More
Doctor shows patient anatomy image of prostate on computer.

NCAPG2 expression behind prostate cancer progression

Prostate cancer is among the leading causes of cancer-related deaths in men. Even though... Read More

TET1 described as a potential pharmacogenomic target for pain

Ten-eleven translocation 1 (TET1) is a member of the TET family of enzymes that promote DNA... Read More

Assembly Biosciences divulges new compounds for HSV, HBV and HDV infections

Assembly Biosciences Inc. has synthesized 2-(imidazo[1, 2-a]1,8-naphthyridin-8-yl)-1,3,4... Read More

Dual inhibition of RET and YES1 could be option in advanced lung cancer

Lung cancer has benefited from the development of targeted therapies for EGFR, MET and ALK... Read More
Colorectal cancer 3D illustration

Bioactive chalcone candidate shows efficacy against colon carcinoma

Researchers from the University of Jeddah and Cairo University have reported the discovery of novel anticancer candidates with efficacy in models of colorectal carcinoma. Read More

Neuron23 describes new TYK2 inhibitors for neurological disorders

Neuron23 Inc. has identified non-receptor tyrosine-protein kinase TYK2 (JH2 domain) inhibitors reported to be useful for the treatment of neurological disorders. Read More

C4 Therapeutics presents new SMARCA2 degradation inducers for cancer

C4 Therapeutics Inc. has divulged proteolysis targeting chimeric (PROTAC) compounds comprising a protein cereblon (CRBN) binding moiety covalently bound to a probable global transcription activator SNF2L2 (SMARCA2; BAF190B; SNF2-α)-targeting moiety through a linker. Read More
Art concept for inflamed human tissue

Targeting CD38 mitigates fibrotic responses in systemic sclerosis

CD38 is the main NAD+-hydrolyzing enzyme, and it also catabolizes nicotinamide mononucleotide (NMN) and other extracellular NAD+ precursors prior to their intracellular transport for NAD+ biosynthesis. Read More

Myrobalan to use series A funding for CNS neurorestorative therapies

Myrobalan Therapeutics Inc. has completed a $24 million series A funding to support development of neurorestorative therapies for CNS diseases. Read More

Amygdala Neurosciences discovers new ALDH2 inhibitors

Amygdala Neurosciences Inc. has described aldehyde dehydrogenase-2 (ALDH2) inhibitors reported to be useful for the treatment of anxiety disorder, binge eating disorder, alcoholism, and amphetamine, cocaine, nicotine and opioid dependence. Read More
Liver tumor treatment conceptual illustration

SPHK1 inhibitor PF-543 blocks liver cancer progression

Hepatocellular carcinoma (HCC) is characterized by a high rate of neovascularization, giving tumoral cells access to nutrients and contributing to disease progression and metastasis. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • In the clinic for April 21, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing